The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Viral Clearance Market During 2026–2030?
The viral clearance market size has witnessed substantial growth in recent years. It is projected to increase from $0.96 billion in 2025 to $1.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. The expansion observed in the historic period can be attributed to limited viral clearance technologies, increasing viral contamination concerns in biologics, reliance on conventional filtration methods, growing regulatory scrutiny, and the expansion of pharmaceutical and biotech manufacturing pipelines.
The market for viral clearance is projected to experience swift expansion over the coming years. Its value is forecast to reach $2.06 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This expansion during the prediction period is largely due to the creation of advanced viral inactivation techniques, the increased use of nanofiltration and membrane chromatography, the boost in manufacturing of biologics and gene therapies, the incorporation of automation into viral clearance processes, and enhanced spending on developing viral detection assays. Key trends anticipated for this period encompass a greater acceptance of sophisticated viral detection and inactivation approaches, an escalating need for secure and virus-free vaccines and treatments, the broadening range of cellular and gene therapy products that necessitate viral clearance, the incorporation of highly efficient filtration and nanofiltration technologies, and an increase in outsourcing viral clearance services to contract research organizations.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27444&type=smp
Which Drivers Are Advancing The Viral Clearance Market Growth?
The anticipated expansion of the viral clearance market going forward is closely linked to the increasing occurrence of chronic diseases. These conditions are defined as persistent health issues that evolve gradually, persisting for extended periods and frequently demanding ongoing treatment or oversight. Globally, the incidence of chronic diseases is on the rise, mainly influenced by demographic shifts towards older populations. Enhanced healthcare and better living standards enable people to live longer, contributing to a surge in age-associated ailments like cardiovascular diseases, diabetes, arthritis, and cancer. For the development of biologics and gene therapies, which are employed in managing chronic diseases, viral clearance plays a vital role in guaranteeing both their safety and efficacy. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, disclosed that more than half a billion individuals worldwide were afflicted with diabetes. Projections indicate this figure will exceed a twofold increase, reaching 1.3 billion people by 2050. Consequently, the expanding occurrence of chronic diseases is acting as a catalyst for the growth of the viral clearance market.
How Are Different Segment Groups Identified Within The Viral Clearance Market?
The viral clearance market covered in this report is segmented –
1) By Method: Viral Clearance Method, Viral Removal Method, Viral Inactivation Method, Viral Detection Method
2) By Application: Vaccines And Therapeutics, Blood And Blood Products, Cellular And Gene Therapy Products, Tissue And Tissue Products, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Other End Users
Subsegments:
1) By Viral Clearance Method: Downstream Processing, Filtration, Chromatography, Precipitation, Nanofiltration
2) By Viral Removal Method: Membrane Chromatography, Depth Filtration, Nanofiltration, Ultrafiltration, Protein A Affinity Chromatography
3) By Viral Inactivation Method: Solvent Detergent Method, Low pH Treatment, Heat Treatment (Pasteurization), UV-C Irradiation, Caprylate Treatment
4) By Viral Detection Method: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Nucleic Acid Testing (NAT), Cell-Based Assays, Transmission Electron Microscopy (TEM)
Which Trends Are Guiding The Development Of The Viral Clearance Market?
Leading companies in the viral clearance market are concentrating on developing innovative products, such as next-generation virus removal filters, to enhance viral safety and improve biopharmaceutical manufacturing efficiency. These next-generation virus removal filters are advanced filtration devices engineered to efficiently remove viruses from biopharmaceutical products, helping to ensure product safety, increase filtration speed, and support higher productivity in drug manufacturing. For instance, in October 2024, Asahi Kasei Medical Co., Ltd., a Japan-based medical and bioprocess solutions company, launched its next-generation Planova FG1 virus-removal filter. This filter offers roughly seven-times higher flux than Planova BioEX, aiming to shorten filtration times, reduce virus-breakthrough risk, and maintain strong protein and virus-removal performance without a prefilter. The FG1 is compatible with standard CIP/SIP processes and entered mass production in smaller sizes, with larger formats planned to support scale-up and enable higher throughput and faster cycle times for biomanufacturers.
Which Key Players Are Active In The Viral Clearance Market?
Major companies operating in the viral clearance market are Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Nelson Labs, Pall Corporation, Sartorius AG, Creative Biolabs, Texcell SA, Vironova AB.
Access The Complete Viral Clearance Market Report:
https://www.thebusinessresearchcompany.com/report/viral-clearance-global-market-report
Which Region Holds The Largest Share In The Viral Clearance Market?
North America was the largest region in the viral clearance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral clearance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Viral Clearance Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=27444&type=smp
Browse Through More Reports Similar to the Global Viral Clearance Market 2026, By The Business Research Company
Wood Manufacturing Market Report 2026
https://www.thebusinessresearchcompany.com/report/wood-manufacturing-global-market-report
Wood Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/wood-products-global-market-report
Wood Processing Market 2026
https://www.thebusinessresearchcompany.com/report/wood-processing-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model